Skip to content
Brand AI

Teva Canada Ltd.

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    Teva Canada recalls two lots of Teva-Pregabalin 150 mg capsules due to sertraline cross-contamination

    Teva Canada Ltd. is recalling two lots of Teva-Pregabalin 150 mg capsules (DIN 02361205, lots 100070495 and 100068913, expiry July 31, 2027) after routine testing identified that some capsules may be contaminated with the drug sertraline. Patients with a hypersensitivity or allergy to sertraline could experience side effects or a serious allergic reaction, including anaphylaxis. Health Canada is monitoring the company's recall and implementation of corrective and preventive actions.

    Source